We are monitoring the impact of COVID-19 on Asia Pacific Intrauterine Devices Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1032
Share on
Share on

Asia Pacific Intrauterine Devices Market Analysis - By Product Type - (Hormonal Intrauterine Device, Copper Intrauterine Device) And By Country (China, India, Japan, Australia, South Korea and Rest of Apac) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: February, 2020
ID: 1032
Pages: 136

Asia Pacific Intrauterine Devices Market Size and Growth Rate (2018-2023):

Asia Pacific Intrauterine Devices (IUD’S) Market was worth USD 399.63 million in 2018 and estimated to reach USD 500.4 million by the end of 2023 with a growing potential of 4.60 %.

Asia Pacific Intrauterine Devices Market - Drivers and Restraints:

Intrauterine devices (IUDs) are contraceptive medical implants used to avoid pregnancies for a long-time period. It is injected into the uterus, and their primary aim is to inhibit the fertilization of the egg by causing changes, such as toxicity or thickening of the cervical mucus, thus inhibiting fertilization by a sperm. Mirena, Skyla and Paragard are some of the prominent brands available in the market. In Asia-Pacific region, most of the people are adopting to modern contraception such as oral pill, injectable contraceptives, condoms, implants, IUDs and male or female sterilisation. Modern contraceptive methods are more effective than traditional methods. For example, the rate of sterilisation fails less than 1 per cent for modern contraception’s in comparison to 25 per cent for periodic abstinence.

Asia Pacific Intrauterine Device market is mainly driven by the factors such as Advancement in technical innovations, increasing prevalence of STD’S (Sexually transmitted diseases), instant health benefits other than birth control, increasing government initiatives to prevent unwanted abortions and pregnancies. The factors that are hindering the growth of the market are issues of Infertility, Religious and cultural opposition, Economic constraints, ectopic pregnancy, pelvic inflammatory infection, and Limited access to contraception.

Asia Pacific Intrauterine Devices Market - Regional Analysis:

On the Basis of Geography, the Asia Pacific Intrauterine Devices Market is bifurcated into China, India, Japan, South Korea, Australia and Rest of Apac.The largest share in the market is held by Hormonal IUD’S. Since, they have less risks compared to non-hormonal IUD’S. Asia-Pacific accounts to hold the largest share in the market.

Few of the promising companies operating in the Asia Pacific Intrauterine Devices Market are:

  1. Agile Therapeutics
  2. Actavis PLC
  3. ANI Pharmaceuticals Inc
  4. Bayer
  5. Teva Pharmaceutical
  6. Besins HealthCare
  7. Brecuro Medical
  8. Effik International
  9. Eurogine, HLL Lifecare
  10. HRA Pharma
  11. Lupin Pharmaceuticals, Ltd
  12. Okamato Industries, Inc
  13. Pfizer

This research report segmented and sub-segmented the Asia Pacific Intrauterine Devices Market into the following categories:

By Product: hormonal and copper IUDs.

By End User: Hospitals, gynecology clinics, community healthcare, and Others.

By Country: China, India, Japan, South Korea, Australia and Rest of Apac.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Hormonal Intrauterine Devices      

                                5.1.2 Copper intrauterine Devices            

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Agile Therapeutics                  

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Actavis PLC                 

                8.3 ANI Pharmaceuticals                              

                8.4 Bayer                            

                8.5 Teva Pharmaceutical                              

                8.6 Besins HealthCare                   

                8.7 Brecuro Medical                       

                8.8 Effik International                    

                8.9 Eurogine                      

                8.10 HLL Lifecare                             

                8.11 HRA Pharma                            

                8.12 Lupin Pharmaceuticals                        

                8.13 Okamato Industries                             

                8.14 Pfizer                          

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific intrauterine Devices Market By Product Type, From 2018-2023( USD Million )  
  2. Asia-Pacific Hormonal Intrauterine Devices Market By Region, From 2018-2023( USD Million )    
  3. Asia-Pacific Copper intrauterine Devices Market By Region, From 2018-2023( USD Million )   
  4. Japan intrauterine Devices Market By Product Type, From 2018-2023( USD Million ) 
  5. China intrauterine Devices Market By Product Type, From 2018-2023( USD Million )  
  6. India intrauterine Devices Market By Product Type, From 2018-2023( USD Million ) 

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample